GlassScriptPhysician profile
Irene Kakossian
NPI 1558381954
$1,613.46
in general payments reported to CMS, 2019-2025
23 companies · $65.93 in 2025
The $65.93 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $129 · 2021: $308 · 2022: $538 · 2023: $108 · 2024: $137 · 2025: $65.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $315.57 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $187.26 | 2022-2025 | |
| Aspira Women'S Health INC | $166.60 | 2022 | |
| Pfizer INC. | $89.23 | 2021-2024 | |
| Evofem Biosciences, INC. | $89.00 | 2020-2022 | |
| Hologic Sales and Service, LLC | $82.76 | 2019-2021 | |
| Shield Therapeutics INC | $79.62 | 2024-2025 | |
| Lupin INC. | $75.26 | 2019-2020 | |
| Exeltis, USA INC. | $75.10 | 2022 | |
| Daiichi Sankyo INC. | $70.08 | 2021-2022 | |
| Myovant Sciences INC. | $63.81 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $40.90 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.01 | 2022 | |
| Allergan, INC. | $37.25 | 2019 | |
| Astellas Pharma US INC | $36.49 | 2023-2024 | Veozah |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $34.64 | 2019 | |
| Coopersurgical, INC. | $27.84 | 2020 | |
| Agile Therapeutics, INC. | $24.18 | 2021 | |
| Scynexis, INC. | $21.05 | 2022 | |
| Gilead Sciences, INC. | $16.82 | 2019 | |
| Dysis Medical, INC. | $14.80 | 2022 | |
| Organon LLC | $14.76 | 2023 | Nexplanon |
| Roche Diagnostics Corporation | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irene Kakossian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.